Page last updated: 2024-10-31

molsidomine and Bone Loss, Osteoclastic

molsidomine has been researched along with Bone Loss, Osteoclastic in 2 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"However the inhibition of bone resorption by SIN-1 in vitro is not mediated solely by cGMP but depends on other factors still unidentified."1.30Nitric oxide superoxide and peroxynitrite modulate osteoclast activity. ( Brandi, ML; MacIntyre, I; Mancini, L; Moradi-Bidhendi, N, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mancini, L1
Moradi-Bidhendi, N1
Brandi, ML1
MacIntyre, I2
Zaidi, M1
Alam, AS1
Datta, HK1
Moonga, BS1
Lidbury, PS1
Hecker, M1
Vane, JR1

Other Studies

2 other studies available for molsidomine and Bone Loss, Osteoclastic

ArticleYear
Nitric oxide superoxide and peroxynitrite modulate osteoclast activity.
    Biochemical and biophysical research communications, 1998, Feb-24, Volume: 243, Issue:3

    Topics: Animals; Animals, Newborn; Bone Resorption; Calcium; Catalase; Cells, Cultured; Cyclic GMP; Enzyme A

1998
Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.
    Proceedings of the National Academy of Sciences of the United States of America, 1991, Apr-01, Volume: 88, Issue:7

    Topics: Animals; Animals, Newborn; Bone Resorption; Calcitonin; Calcium; Cell Membrane; Cells, Cultured; Cyc

1991